Revisiting Stage IIIB and IV Non-Small Cell Lung Cancer: Analysis of the Surveillance, Epidemiology, and End Results Data

Chest. 2009 Sept 1;136(3):701-709, WN William, Jr, HY Lin, J Lee, SM Lippman, JA Roth, ES Kim

TAKE-HOME MESSAGE

Abstract

Abstract

Approximately 46% of patients with newly diagnosed cases of non−small cell lung cancer (NSCLC) are at stages IIIB or IV. Prognoses differences among subgroups of these patients exist, but are not well understood. Based on a large multinational database, a new TNM classification system was proposed by International Association for the Study of Lung Cancer that redefined T3, T4, M1, and M1a subgroups based on the locations of nodules and the presence or absence of pleural effusion and extrathoracic...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

About Our Journal Scans

View a list of journals that the OncologySTAT editorial team scans every week in order to bring you the most practice-relevant original research and review articles.

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration